Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Sweden Q3 Operating Revenue Rises To SEK 434,672

Nov 19 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * Q3 OPERATING REVENUE SEK 434,672 VERSUS SEK 110,718 YEAR
AGO
    * Q3 PRE TAX PROFIT SEK 3.0 MILLION VERSUS SEK 2.6 MILLION
YEAR
AGO

Source text for Eikon:  ID:nWkrDBvl2 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Bio Vitos Pharma AB

See all news